US Patent Issued to Shenzhen Enduring Biotech on Sept. 30 for "Long acting multi-specific molecules and related methods" (New Jersey Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,203, issued on Sept. 30, was assigned to Shenzhen Enduring Biotech Ltd. (Shenzhen, China).

"Long acting multi-specific molecules and related methods" was invented by Shu-min Liu (Monmouth Junction, N.J.) and Dechun Wu (Bridgewater, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to multi-specific molecules, such as long acting multi-specific antibodies. Also disclosed are related methods."

The patent was filed on July 12, 2021, under Application No. 17/373,296.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%...